SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Neil Johnson F. Reviews in Contemporary Pharmacotherapy 1999; 10(4): 193-265.

Copyright

(Copyright © 1999)

DOI

unavailable

PMID

unavailable

Abstract

Ores containing lithium were discovered in 1800. The new element was named in 1818 and lithium metal was first isolated in the same year. The first recorded medical use of lithium was in 1859 when it was used in the treatment of gout. The uric acid diathesis concept linked gout to a wide variety of other conditions, including mania and depression, and it was as a result of this that lithium was used to treat both of these latter conditions in the late 19th century. Although the uric acid diathesis concept persisted well into the 20th century, the use of lithium in medicine gradually died out, until in 1949 it was again successfully used in the treatment of manic excitement. At about the same time, however, there were reports of toxicity arising from the uncontrolled ingestion of lithium sails used as taste substitutes for sodium chloride. Lithium therapy for mania was investigated only sporadically over the next few years until the appearance in 1954 of a report which not only confirmed the therapeutic efficacy of lithium against this condition, but also showed that adverse effects of lithium could be controlled by monitoring serum lithium levels. In the early-to-mid 1960s, it was suggested that lithium not only acted acutely against mania, but could be used prophylactically to prevent recurrent depressive episodes. This finding was at first challenged on methodological and statistical grounds, the claim for prophylactic efficacy being branded a 'therapeutic myth.' Subsequent work, however, demonstrated that the claims for prophylactic efficacy were well-founded and this led to the establishment of lithium treatment as a major therapeutic modality in modern psychiatric practice. The use of lithium spread throughout the world, with particular interest being shown in the USA and UK where confirmatory studies were conducted. Whilst some claims were made for an acute antidepressant effect of lithium, this appeared limited to a subgroup of depressed patients; similarly, lithium was effective is schizophrenic patients only to the extent that it reduced associated manic excitement. A number of crises arose in the early years of lithium therapy, which seemed to pose a threat to the establishment of this treatment: these included reports of possible effects on the thyroid and kidney. However, later work showed that none of these effects was serious and that, properly managed, lithium therapy was both safe and effective. Lithium has now an established place in psychiatric practice, although the introduction of newer antidepressants has, to some extent, reduced the extent to which lithium is used. It remains the case, however, that lithium has properties not possessed by the antidepressants, including the potential to reduce suicide rates in at-risk populations, and the future may see a resurgence in the popularity of this medication. The history of lithium therapy provides a fascinating glimpse into the social and historical forces which have shaped modern medicine and the conceptual systems upon which present-day treatments are founded.


Language: en

Keywords

anorexia; antidepressant agent; bladder stone; bradycardia; chemoprophylaxis; chlorpromazine; clinical trial; depression; dyspepsia; gout; history of medicine; human; lithium; lithium carbonate; malaise; mania; mineral water; nausea; nephrolithiasis; psychiatry; review; schizophrenia; side effect; tremor; uric acid; vomiting

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print